Course “Modeling for systems biology and biomedicine” at the Faculty of Bioengineering and Bioinformatics

NEWS
Education
November 18, 2019

November 18, 2019

This year InSysBio CEO Dr Oleg Demin with expert modelers Tatiana Karelina and Evgeny Metelkin and modelers Dmitry Shchelokov, Svetlana Rubina and Veronika Musatova are giving the course “Modeling for systems biology and biomedicine” at the Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University.

The course will give an introduction to quantitative systems pharmacology (QSP) modeling and summary of general principles of development of mathematical models of biological systems, such as enzyme kinetics, metabolic and signaling pathways and cell dynamics. Dr Demin will show students how to describe pharmacokinetics and how to implement interaction between drugs and targets in the model. The course program is based on cases of various modeling approaches for biomedical and pharmacological problems solving. The course is given annually at the Faculty of bioengineering and bioinformatics, in addition InSysBio expert modelers give lectures on modeling for systems biology at the Faculty of Physics.

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

February 2020
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
1. 19 Feb 2020 12:54 InSysBio to participate in ASCPT 2020 InSysBio announced its participation in 121st Annual meeting of American Society for Clinical Pharmacology and Therapeutics (ASCPT 2020) which is to be held on March 18-21, 2020 at Marriott Marquis Houston, TX. InSysBio welcomes visitors at the booth # 102. Oleg Demin, CEO of InSysBio, Tatiana Karelina, lead modeler in Alzheimer's Disease and Veronika Musatova, Head of IRT development team, will present the new version of IRT (Immune Response Template) and Cytocon DB (Cell and cYTOkine CONcentrations).
20
21
1. 21 Feb 2020 17:02 InSysBio presents an enhanced version of its Immune Response Template Database IRT Version 3.0.0 acquires a wide variety of updates and new options (Moscow – 21.02.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, moves forward to the future.
22
23
24
25
26
27
28
29
 
Upcoming Events
Tags
Latest News
10.09
InSysBio team to publish the new article in PSPJournal
04.09
InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling
22.02
14th InSysBio’s Annual Internal Scientific Meeting
24.01
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online
07.12
InSysBio to release public beta of fIVE Calculator